TLP Group’s Voyager Therapeutics VYGR Stock Holding History

TLP Group’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,028	Closed	-$48K	–	385
2016 Q3	$48K	Buy	+4,028	New	+$54.5K	0.05%	268

Other funds holding VYGR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TLP Group's VYGR Position: Q4 2016 in Review

TLP Group sold out of Voyager Therapeutics (VYGR) in Q4 2016, closing a stake of 4,028 shares — an estimated $48K sold.

TLP Group first reported a position in VYGR in Q3 2016 and held it in 1 quarter. The position peaked at $48K in Q3 2016. 56 funds tracked by Wall St. Rank hold VYGR as of Q4 2016.

TLP Group reported no remaining Voyager Therapeutics position as of Q4 2016 after selling out during the quarter.
TLP Group sold 4,028 Voyager Therapeutics shares in Q4 2016, an estimated $48K.
TLP Group first reported a position in Voyager Therapeutics in Q3 2016 and held it in 1 quarter.
TLP Group's Voyager Therapeutics position peaked at $48K in Q3 2016.
56 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2016.

Based on TLP Group's 13F filing for Q4 2016, filed 2 Feb 2017.